Credit: Shutterstock photoAmerican Renal Associates Holdings, which operates 192 kidney dialysis clinics through joint ventures with physicians, raised $165 million by offering 7.5 million shares at $22, within the range of $20 to $23. American Renal Associates Holdings plans to list on the NYSE under the symbol ARA. BofA Merrill Lynch, Barclays, Goldman Sachs, Wells Fargo Securities and SunTrust Robinson Humphrey acted as lead managers on the deal.
The article American Renal Associates prices IPO at $22, within the range originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
